Clinical Study
Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
Table 1
Patient characteristics (): no significant difference in age, KPS, number of brain metastases, extracranial metastases, primary tumour control, DS-GPA and RPA classification, radiation dose, and time interval ( or more); significant difference: primary disease type ().
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KPS: Karnofsky performance status; BM: brain metastases; DS-GPA: diagnosis-specific graded prognostic assessment; NSCLC: nonsmall cell lung cancer; SCLC: small cell lung cancer; MM: malignant melanoma; GI: gastrointestinal primary tumour. |